fashion -WSS

fashion

author：entertainment 2025-09-28 00:50:54 - browse：9197

Silhouette of a medical staff, followed by another, running pushing a nursing bed. Two people talk next to the hurrying staff in the corridor — coverage from STAT — Adobe

There’s ample evidence that private equity buyouts in health care drive up costs. A new study shows quality declines, too.

Hospitals acquired by private equity saw a 25% uptick in adverse events compared with controls, according to a new study released today in the Journal of the American Medical Association. The findings add to an accumulating body of literature underscoring the harm that occurs when financial investors take over health care providers — not only hospitals, but nursing homes, hospice care, and physician practices.

Even after adjusting their findings to be more conservative, the researchers on the JAMA study found that all of the hospital-acquired conditions they studied increased three years after a private equity acquisition compared to control hospitals. Not all of the increases were statistically significant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Reports of telehealth's death have been greatly exaggerated

WSS

Digital health: a case of mistaken identity

Heart disease and mental health: A look at cardiac psychology

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

How I ended up pumping milk in a bathroom stall at JPM 2024

As JPM 2024 winds down, some health tech firms project optimism

entertainment

fashion

Wikipedia

Alkermes shareholders re

UnitedHealth argues against case alleging wrongful AI care denials

Psychedelics group wrestles with new pharma identity

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Trump demands the U.S. pay no more for drugs than other countries … again

Fentanyl is making it harder to start addiction treatment

Bright Health sells Medicare Advantage business to Molina

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Cancer drug shortages should be causing more outrage

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Wikipedia

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Three issues to watch in global health in 2024

Questions and answers about ramping up H5N1 bird flu vaccine

FDA poised to publish guidelines for clinical trial diversity

Study finds gene variants tied to breast cancer risk in Black women

Three issues to watch in global health in 2024

focus

leisure time

leisure time

Wikipedia